6 developments in GI tech

From leadership appointments to partnerships, here are six updates from gastroenterology medtech companies since June 1:

Advertisement

1. The FDA on June 1 cleared the first 360-degree colonoscope. Saneso’s colonoscope has a 360-degree multidirectional view with five cameras, according to a news release. Traditional colonoscopes have a 140- to 170-degree field of view, which causes them to miss up to 40 percent of polyps

2. Iterative Scopes, a gastroenterology-focused software company, selected Aditya Khosla, PhD, as its chief technology officer

3. 3D printing firm Triastek has partnered with Eli Lilly, a global pharmaceutical company, to develop 3D-printed oral gastrointestinal drugs.

4. Pittsburgh-based logistics platform Mobile Aspects received patent approval for its iRIScope system, an endoscope storage cabinet that uses automated-channel drying and RFID technology.

5. Virgo, an endoscopy video technology company, signed an exclusive partnership agreement with AI gastroenterology solutions company Satisfai Health.

6. Iterative Scopes, a gastroenterology-focused software company, appointed Shrujal Baxi, MD, chief medical officer.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • OSF HealthCare Saint Anthony Medical Center in Rockford, Ill., has added Tarik Firozi, MD, according to an April 6 report…

  • Miami-based Gastro Health has finalized a partnership with Digestive Disease Physicians, an Alexandria, Va.-based gastroenterology practice, according to an April…

  • Birmingham (Ala.) Gastroenterology has opened a clinic in Jasper, Ala., expanding access to digestive health services in the region, the…

Advertisement

Comments are closed.